Tanvex BioPharma USA, Inc. | WebDisclosure

Basculer en Français

10707	Companies
229232	Keywords
157864	Articles
121758	Press releases

Headlines Articles Press releases Tanvex BioPharma USA, Inc.

Home
Companies
Tanvex BioPharma USA, Inc.

BRIEF

published on 08/19/2024 at 13:05, 1 year 10 months ago

Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi(TM) and FDA Accepts Biosimilar Biologics License Application for TX-05

FDA Approval Cancer Treatment Healthcare Innovation Biosimilar Neutropenia
BRIEF

published on 08/19/2024 at 13:05, 1 year 10 months ago

Tanvex BioPharma USA, Inc. franchit deux étapes réglementaires aux États-Unis : la FDA approuve Nypozi(TM) et la FDA accepte la demande de licence de produits biologiques biosimilaires pour le TX-05

Traitement Du Cancer Approbation De La FDA Biosimilaire Innovation Dans Le Domaine De La Santé Neutropénie
PRESS RELEASE

published on 08/19/2024 at 13:00, 1 year 10 months ago

Tanvex BioPharma USA, Inc. Achieves Dual U.S. Regulatory Milestones: FDA Approves Nypozi(TM) and FDA Accepts Biosimilar Biologics License Application for TX-05
Tanvex BioPharma USA, Inc. receives FDA approval for NYPOZI™ biosimilar and FDA BLA acceptance for TX-05, showcasing expertise in biologics development and manufacturing

FDA Approval Biologics Tanvex BioPharma NYPOZI TX-05
PRESS RELEASE

published on 10/16/2023 at 14:00, 2 years 8 months ago

Tanvex CDMO Launch Empowers Advancements in Novel Biologics and Biosimilars

Accesswire

Published on 07/13/2026 at 03:25, 6 hours 21 minutes ago

SouthGobi Announces Inside Information JD Zhixing Fund L.P. Assigns Payment-In-Kind Interest Under Convertible Debenture
Published on 07/11/2026 at 02:50, 2 days 6 hours ago

Alaska Energy Metals Reports on At-the-Market Equity Financing Program
Published on 07/11/2026 at 02:00, 2 days 7 hours ago

Battery X Metals Presents Positive Preliminary Lithium-Ion Battery Rebalancing Trial Results Demonstrating Significant Estimated Driving Range Improvements and Accelerated Commercialization Progress of its Patent-Pending Lithium-Ion Battery Rebalancing Te
Published on 07/11/2026 at 02:00, 2 days 7 hours ago

Discovery Energy Metals Announces Non-Brokered Private Placement Financing
Published on 07/11/2026 at 00:00, 2 days 9 hours ago

Onco-Innovations Completes Analytical Reference Standard Preparation Program for ONC010’s API

View all ACCESSWIRE

EQS Group

Published on 07/13/2026 at 09:36, 10 minutes ago

Aareal Bank finances the acquisition of Marriott Zurich for Pictet Real Estate Capital
Published on 07/13/2026 at 09:20, 26 minutes ago

DN Group AG: Investment in Algene starts series production of high-quality microalgae
Published on 07/13/2026 at 09:00, 46 minutes ago

Municipality Finance issues EUR 70 million zero coupon notes under its MTN programme
Published on 07/13/2026 at 09:00, 46 minutes ago

Municipality Finance issues EUR 50 million zero coupon notes under its MTN programme
Published on 07/13/2026 at 09:00, 46 minutes ago

Official List Notice

Les Echos

Published on 07/13/2026 at 09:20, 25 minutes ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 mai 2026 bis
Published on 07/13/2026 at 07:30, 2 hours 16 minutes ago

Déclaration hebdomadaire d'opérations effectuées du 6 au 10 juillet 2026
Published on 07/13/2026 at 07:30, 2 hours 16 minutes ago

Disclosure of transactions in own shares from July 6 to July 10, 2026
Published on 07/10/2026 at 18:00, 2 days 15 hours ago

Half-year liquidity contract statement for CEGEDIM
Published on 07/10/2026 at 18:00, 2 days 15 hours ago

Bilan semestriel du contrat de liquidité de la société CEGEDIM

View all LES ECHOS COMFI WIRE